HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chemoradiation therapy for squamous cell carcinoma of anal canal cancer: report of a case.

Abstract
We report a case of anal canal cancer in a 65-year-old woman who had complained of bloody stool. Physical examination revealed a 2.5 cm ulcerated tumor in the anterior wall of the anal canal astride the dentate line. Histological examination of biopsy specimens confirmed the diagnosis of moderately differentiated squamous cell carcinoma. Chemoradiation therapy included whole pelvic irradiation amounting to 4140 cGy followed by conformal boost irradiation of 2000 cGy and 5-fluorouracil div 750 mg/24 hr 3 days, mitomycin C iv 10 mg day 1, and cisplatinum div 50 mg day 2. Six weeks later the tumor had completely regressed, and there was no evidence of recurrence 21 months later. Her anorectal function was retained.
AuthorsH Ando, T Nishimura, T Nakamura, H Sugimura, S Nakamura
JournalRadiation medicine (Radiat Med) 2000 May-Jun Vol. 18 Issue 3 Pg. 199-203 ISSN: 0288-2043 [Print] Japan
PMID10972551 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Mitomycin
  • Cisplatin
  • Fluorouracil
Topics
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Anus Neoplasms (drug therapy, radiotherapy)
  • Carcinoma, Squamous Cell (drug therapy, radiotherapy)
  • Cisplatin (administration & dosage)
  • Combined Modality Therapy
  • Female
  • Fluorouracil (administration & dosage)
  • Humans
  • Mitomycin (administration & dosage)
  • Radiotherapy Dosage

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: